Back to Authors

Singh, Rashmi B. Halker

https://orcid.org/0000-0002-4280-4440

Mayo Clinic

Mayo Clinic

Citations 54

The Headache Innovation Challenge: An outgrowth of the AHS/NINDS Headache research priorities
Vallimont, Jenn , Singh, Rashmi B. Halker , Charleston, Larry , Gelfand, Amy A. , Halker Singh, Rashmi B , Charleston, Larry , Gelfand, Amy A

Headache: The Journal of Head and Face Pain | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/head.70230 Get It

Beyond “other”: Exploring representation of minoritized individuals in headache research
Cheng, Nan , Singh, Rashmi B. Halker , Halker Singh, Rashmi B , Cheng, Nan

Headache: The Journal of Head and Face Pain | July 19, 2025 | Volume: 65 | Issue: 8 | Pages: 1460-1461

10.1111/head.15013 Get It

Impact of Atogepant on Activity Limitation in Participants With Episodic Migraine and Chronic Migraine: Post Hoc Analyses of ADVANCE, ELEVATE, and PROGRESS (P9-12.004)
Gandhi, Pranav , Dabruzzo, Brett , Umashankar, Kandavadivu , Duan, Molly, Stokes, Jonathan , Buse, Dawn C. , Lipton, Richard B. , Singh, Rashmi B. Halker , Yuan, Hsiangkuo , Gantenbein, Andreas R.

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208534 Get It

Network Meta-Analysis Comparing Efficacy and Safety Outcomes of Atogepant, Rimegepant, and Galcanezumab in Patients with Episodic Migraine After Including CHALLENGE-MIG Trial (P9-12.007)
Gandhi, Pranav , Lalla, Anjana, McAllister, Peter , Bilchik, Tanya R., Rowe, David A. , Piron, Cristiano, Kelton, Kari , Ailani, Jessica , Lalla, Anjana, Nahas, Stephanie J. , Rowe, David, Singh, Rashmi B. Halker

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210714 Get It

Impact of Atogepant on Daily Functioning in Patients with Episodic Migraine and Chronic Migraine: Activity Impairment in Migraine-Diary (AIM-D) Item-Level Analysis (P12-12.004)
Lipton, Richard, Gandhi, Pranav , Buse, Dawn C. , Stokes, Jonathan , Umashankar, Kandavadivu , Dabruzzo, Brett , Duan, Molly, Lipton, Richard B. , Singh, Rashmi B. Halker , Yuan, Hsiangkuo , Gantenbein, Andreas R.

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210708 Get It

Economic Impact of Early Vs. Late Initiation of Atogepant for The Preventive Treatment of Migraine (P10-12.007)
Lalla, Anjana, Gandhi, Pranav , Carr, Karen, Dabruzzo, Brett , Ailani, Jessica , Lalla, Anjana, Singh, Rashmi B. Halker , Lipton, Richard B.

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208979 Get It

More Than “Other”: Exploring Representation of Minoritized Individuals in Headache Research (P3-12.003)
Cheng, Nan , Singh, Rashmi B. Halker

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211406 Get It

Representation of neuro-oncology in American neurology departments: An analysis of Grand Rounds and perspectives from faculty and residents
Neil, Elizabeth , Bruhnding, Aubree , Ahmed, Zubair , Kumthekar, Priya , Blondin, Nicholas, Patel, Chirag B, Hsu, Sigmund, Wang, Feng , Rosen, Noah , Burish, Mark J. , Corbin, Zachary , Patel, Chirag B. , Neil, Elizabeth C , Kumthekar, Priya , Grommes, Christian , Patel, Chirag B, Miao, Hongyu , Singh, Rashmi B. Halker

Neuro-Oncology Practice | March 17, 2025 | Volume: 12 | Issue: 6 | Pages: 1121-1129

10.1093/nop/npaf033 Get It

Abstract Background Neuro-oncology education in American neurology departments is highly variable, with no clear guidelines on appropriate practices. To better understand its current state, we focus on the perspective of departmental Grand Rounds (GR), views of adult neurology residency program directors (ANRPD), neuro-oncologists, and residents. Methods First, we obtained GR series from academic years 2017–2018 and 2018–2019 via an online search and direct emails to neurology residency programs. Second, two online surveys were dispensed to ANRPD and neuro-oncologists. Third, a cohort of neurology residents completed surveys with pre/post-didactic tests. Results Neuro-oncology consisted of 7% (28/ 411) GR in 2017–2018 and 6% (29/463) in 2018–2019; approximately 20% of institutions had no neuro-oncology GR. Twenty neuro-oncologists and 25 of the 175 ANRPDs completed the surveys. Respondents thought 1-to-4 GR annually was adequate. Thirty-five residents completed the survey. Residents might consider neuro-oncology with more exposure (77%, 27/35) and a stronger knowledge base (57%, 20/35). After 8-hours of didactics, residents demonstrated significant (P = .019) pre-/post-test improvement. Conclusions Here, we begin to define the status of several aspects of neuro-oncology education: 1 in 5 academic institutions do not have any neuro-oncology GR lectures annually, and both ANRPDs and neuro-oncologists agree that 1-to-4 lectures annually are adequate. Residents overwhelmingly stated they would be more interested in neuro-oncology with more exposure, and a pilot study of 8 hours of didactic did show knowledge improvement. While these initial datasets require confirmation in larger studies, it suggests that small changes to the current state at some institutions could have a meaningful impact.